Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mitochondria | 31 | 2023 | 454 | 4.260 |
Why?
|
HIV Infections | 45 | 2023 | 2207 | 3.340 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 11 | 2019 | 31 | 3.270 |
Why?
|
DNA, Mitochondrial | 27 | 2023 | 165 | 3.120 |
Why?
|
Anti-HIV Agents | 17 | 2022 | 394 | 2.770 |
Why?
|
Leukocytes, Mononuclear | 15 | 2021 | 224 | 2.110 |
Why?
|
Adipose Tissue | 9 | 2019 | 167 | 2.070 |
Why?
|
Reverse Transcriptase Inhibitors | 10 | 2019 | 55 | 1.750 |
Why?
|
Insulin Resistance | 7 | 2022 | 177 | 1.600 |
Why?
|
Adenine | 5 | 2012 | 43 | 0.920 |
Why?
|
Zidovudine | 10 | 2022 | 33 | 0.920 |
Why?
|
HIV-1 | 10 | 2020 | 678 | 0.830 |
Why?
|
Adipocytes | 2 | 2019 | 54 | 0.800 |
Why?
|
Cholesterol | 2 | 2020 | 194 | 0.790 |
Why?
|
Antiretroviral Therapy, Highly Active | 7 | 2013 | 219 | 0.710 |
Why?
|
Maternal-Fetal Exchange | 5 | 2011 | 29 | 0.710 |
Why?
|
Monocytes | 4 | 2016 | 258 | 0.680 |
Why?
|
Stavudine | 6 | 2015 | 13 | 0.680 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 180 | 0.670 |
Why?
|
Female | 50 | 2022 | 19873 | 0.650 |
Why?
|
Humans | 62 | 2023 | 34853 | 0.650 |
Why?
|
Male | 46 | 2021 | 18870 | 0.640 |
Why?
|
Inflammation | 5 | 2017 | 577 | 0.610 |
Why?
|
Mitochondria, Heart | 7 | 2016 | 66 | 0.590 |
Why?
|
Mitochondrial Diseases | 3 | 2021 | 16 | 0.590 |
Why?
|
Oxidative Phosphorylation | 9 | 2020 | 49 | 0.580 |
Why?
|
Adult | 28 | 2021 | 11034 | 0.530 |
Why?
|
Anti-Retroviral Agents | 7 | 2022 | 139 | 0.510 |
Why?
|
Lamivudine | 5 | 2012 | 20 | 0.500 |
Why?
|
Cross-Sectional Studies | 14 | 2021 | 2561 | 0.470 |
Why?
|
Middle Aged | 26 | 2020 | 9642 | 0.460 |
Why?
|
Peripheral Nervous System Diseases | 5 | 2015 | 26 | 0.430 |
Why?
|
Uridine | 1 | 2011 | 5 | 0.420 |
Why?
|
Mitochondria, Liver | 2 | 2001 | 15 | 0.420 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2011 | 99 | 0.410 |
Why?
|
Nucleosides | 1 | 2011 | 27 | 0.390 |
Why?
|
Cohort Studies | 7 | 2020 | 1422 | 0.380 |
Why?
|
Macrophages | 1 | 2014 | 431 | 0.370 |
Why?
|
RNA | 2 | 2011 | 234 | 0.360 |
Why?
|
Subcutaneous Fat | 3 | 2019 | 12 | 0.360 |
Why?
|
Metformin | 2 | 2020 | 64 | 0.350 |
Why?
|
Acetylcarnitine | 2 | 2009 | 8 | 0.350 |
Why?
|
Pregnancy | 11 | 2022 | 1503 | 0.350 |
Why?
|
Endodeoxyribonucleases | 2 | 2002 | 29 | 0.340 |
Why?
|
HIV Seropositivity | 2 | 2012 | 182 | 0.320 |
Why?
|
T-Lymphocytes | 2 | 2021 | 341 | 0.310 |
Why?
|
Electron Transport Complex IV | 6 | 2019 | 35 | 0.300 |
Why?
|
Cell Respiration | 2 | 2017 | 33 | 0.300 |
Why?
|
CD4 Lymphocyte Count | 8 | 2020 | 185 | 0.300 |
Why?
|
Pilot Projects | 6 | 2020 | 628 | 0.300 |
Why?
|
Skin | 3 | 2015 | 173 | 0.290 |
Why?
|
Adiponectin | 2 | 2019 | 52 | 0.280 |
Why?
|
Population | 1 | 2005 | 7 | 0.270 |
Why?
|
HIV Seronegativity | 2 | 2005 | 38 | 0.270 |
Why?
|
Cognition | 2 | 2020 | 373 | 0.270 |
Why?
|
Mitochondria, Muscle | 2 | 2001 | 16 | 0.260 |
Why?
|
Blood Coagulation Disorders | 2 | 2016 | 6 | 0.250 |
Why?
|
Muscle, Skeletal | 3 | 2004 | 257 | 0.250 |
Why?
|
Nerve Fibers | 4 | 2014 | 36 | 0.250 |
Why?
|
Schools, Medical | 2 | 2018 | 192 | 0.250 |
Why?
|
Viral Load | 5 | 2019 | 300 | 0.250 |
Why?
|
Mitochondrial Proteins | 2 | 2019 | 96 | 0.250 |
Why?
|
Case-Control Studies | 5 | 2020 | 1056 | 0.250 |
Why?
|
Fetus | 1 | 2004 | 103 | 0.240 |
Why?
|
Oxidative Stress | 5 | 2019 | 874 | 0.230 |
Why?
|
Adolescent | 8 | 2021 | 5035 | 0.230 |
Why?
|
Deoxyguanosine | 2 | 2016 | 34 | 0.230 |
Why?
|
Erythrocebus patas | 5 | 2004 | 5 | 0.220 |
Why?
|
Ritonavir | 3 | 2012 | 14 | 0.220 |
Why?
|
Child | 6 | 2021 | 2875 | 0.220 |
Why?
|
Genome, Viral | 1 | 2023 | 103 | 0.220 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2022 | 6 | 0.220 |
Why?
|
Neuroblastoma | 1 | 2023 | 128 | 0.220 |
Why?
|
Fibrin Fibrinogen Degradation Products | 3 | 2017 | 12 | 0.220 |
Why?
|
Immunity, Innate | 1 | 2023 | 135 | 0.220 |
Why?
|
Selenoproteins | 2 | 2022 | 151 | 0.220 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2021 | 2 | 0.210 |
Why?
|
Fibroblast Growth Factors | 1 | 2021 | 34 | 0.210 |
Why?
|
Interleukin-6 | 3 | 2017 | 140 | 0.210 |
Why?
|
Sensory Receptor Cells | 2 | 2015 | 31 | 0.210 |
Why?
|
Brain | 5 | 2019 | 1268 | 0.200 |
Why?
|
Cisplatin | 1 | 2001 | 70 | 0.200 |
Why?
|
Ethanolamine | 1 | 2021 | 8 | 0.200 |
Why?
|
Diabetes, Gestational | 1 | 2021 | 46 | 0.190 |
Why?
|
Aged | 8 | 2019 | 6448 | 0.190 |
Why?
|
Mitochondrial Myopathies | 1 | 2000 | 1 | 0.190 |
Why?
|
Fetal Heart | 1 | 2000 | 5 | 0.190 |
Why?
|
Veterans | 3 | 2017 | 115 | 0.190 |
Why?
|
Lipase | 1 | 2020 | 16 | 0.190 |
Why?
|
Infant | 4 | 2022 | 1014 | 0.190 |
Why?
|
Phospholipids | 1 | 2021 | 68 | 0.190 |
Why?
|
Cyclopropanes | 3 | 2021 | 39 | 0.180 |
Why?
|
Alkynes | 3 | 2021 | 49 | 0.180 |
Why?
|
Benzoxazines | 3 | 2021 | 46 | 0.180 |
Why?
|
DNA Copy Number Variations | 2 | 2018 | 27 | 0.180 |
Why?
|
Polyneuropathies | 2 | 2012 | 10 | 0.180 |
Why?
|
Animals | 14 | 2022 | 14307 | 0.170 |
Why?
|
Treatment Outcome | 3 | 2012 | 1349 | 0.170 |
Why?
|
DNA Damage | 3 | 2016 | 341 | 0.170 |
Why?
|
Coronary Artery Disease | 2 | 2017 | 147 | 0.170 |
Why?
|
NADH Dehydrogenase | 3 | 2011 | 7 | 0.160 |
Why?
|
Placenta | 3 | 2004 | 91 | 0.160 |
Why?
|
Microscopy, Electron | 3 | 2004 | 186 | 0.150 |
Why?
|
Oxygen Consumption | 1 | 2017 | 98 | 0.150 |
Why?
|
Physical Fitness | 1 | 2017 | 78 | 0.150 |
Why?
|
Heart | 2 | 2000 | 178 | 0.150 |
Why?
|
Prospective Studies | 6 | 2018 | 1353 | 0.150 |
Why?
|
Atrophy | 1 | 2016 | 40 | 0.140 |
Why?
|
Energy Metabolism | 1 | 2017 | 160 | 0.140 |
Why?
|
Cardiotonic Agents | 1 | 2016 | 35 | 0.140 |
Why?
|
Curriculum | 1 | 2018 | 237 | 0.140 |
Why?
|
Young Adult | 3 | 2021 | 4012 | 0.140 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 37 | 0.140 |
Why?
|
Doxorubicin | 1 | 2016 | 80 | 0.130 |
Why?
|
Cause of Death | 1 | 2016 | 154 | 0.130 |
Why?
|
Mortality | 1 | 2016 | 150 | 0.130 |
Why?
|
Molecular Biology | 1 | 2015 | 44 | 0.130 |
Why?
|
Lipoproteins, HDL | 1 | 2014 | 43 | 0.130 |
Why?
|
Lipoproteins, LDL | 1 | 2014 | 61 | 0.130 |
Why?
|
Epidermis | 1 | 2014 | 26 | 0.130 |
Why?
|
Infant, Newborn | 2 | 2022 | 871 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 178 | 0.120 |
Why?
|
Antineoplastic Agents | 1 | 2001 | 756 | 0.120 |
Why?
|
Nervous System Diseases | 1 | 2014 | 66 | 0.120 |
Why?
|
Polymerase Chain Reaction | 3 | 2011 | 430 | 0.120 |
Why?
|
Dilatation, Pathologic | 1 | 2013 | 9 | 0.120 |
Why?
|
Longitudinal Studies | 4 | 2019 | 841 | 0.120 |
Why?
|
Research | 1 | 2015 | 159 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2017 | 638 | 0.120 |
Why?
|
RNA, Viral | 3 | 2020 | 287 | 0.120 |
Why?
|
Dideoxynucleosides | 1 | 2012 | 11 | 0.110 |
Why?
|
Obesity | 2 | 2019 | 965 | 0.110 |
Why?
|
Succinate Dehydrogenase | 3 | 2001 | 7 | 0.110 |
Why?
|
Cell Nucleus | 1 | 1995 | 351 | 0.110 |
Why?
|
Deoxycytidine | 1 | 2012 | 21 | 0.110 |
Why?
|
Drug Combinations | 1 | 2012 | 89 | 0.110 |
Why?
|
Pyrimidinones | 2 | 2009 | 9 | 0.110 |
Why?
|
Botswana | 2 | 2022 | 5 | 0.110 |
Why?
|
Hippocampus | 1 | 2016 | 546 | 0.110 |
Why?
|
DNA Repair | 1 | 1994 | 181 | 0.110 |
Why?
|
Oligopeptides | 1 | 2012 | 97 | 0.110 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 217 | 0.110 |
Why?
|
Exercise | 1 | 2017 | 524 | 0.110 |
Why?
|
Pyridines | 1 | 2012 | 113 | 0.110 |
Why?
|
Neurotoxicity Syndromes | 1 | 2012 | 32 | 0.110 |
Why?
|
Universities | 1 | 2015 | 363 | 0.110 |
Why?
|
Oxidoreductases | 3 | 2019 | 82 | 0.110 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2021 | 67 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2011 | 30 | 0.100 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2011 | 12 | 0.100 |
Why?
|
Bone Density | 1 | 2011 | 76 | 0.100 |
Why?
|
Pathology, Molecular | 1 | 2011 | 9 | 0.100 |
Why?
|
Viremia | 1 | 2011 | 40 | 0.100 |
Why?
|
Niacin | 1 | 2010 | 23 | 0.090 |
Why?
|
Hawaii | 4 | 2020 | 1878 | 0.090 |
Why?
|
Cholesterol, HDL | 1 | 2010 | 87 | 0.090 |
Why?
|
Vasodilation | 1 | 2010 | 65 | 0.090 |
Why?
|
Extremities | 1 | 2009 | 17 | 0.090 |
Why?
|
Vitamin D | 1 | 2011 | 176 | 0.090 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 73 | 0.090 |
Why?
|
F2-Isoprostanes | 1 | 2009 | 20 | 0.090 |
Why?
|
Body Fat Distribution | 1 | 2009 | 23 | 0.090 |
Why?
|
Lymphocyte Activation | 2 | 2020 | 222 | 0.090 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2009 | 41 | 0.090 |
Why?
|
United States | 5 | 2018 | 3894 | 0.090 |
Why?
|
Nevirapine | 2 | 2022 | 7 | 0.090 |
Why?
|
Risk Factors | 5 | 2017 | 3414 | 0.080 |
Why?
|
Mice, Knockout | 2 | 2022 | 897 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 2 | 2016 | 528 | 0.080 |
Why?
|
Embryonic and Fetal Development | 2 | 2001 | 37 | 0.080 |
Why?
|
Glutathione | 1 | 2009 | 160 | 0.080 |
Why?
|
Reactive Oxygen Species | 2 | 2023 | 416 | 0.080 |
Why?
|
Prevalence | 2 | 2018 | 1425 | 0.080 |
Why?
|
Peripheral Nerves | 1 | 2007 | 14 | 0.080 |
Why?
|
Cattle | 2 | 2002 | 472 | 0.080 |
Why?
|
Sensation Disorders | 1 | 2006 | 2 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2008 | 229 | 0.070 |
Why?
|
Alleles | 2 | 2018 | 284 | 0.070 |
Why?
|
Follow-Up Studies | 2 | 2021 | 964 | 0.070 |
Why?
|
Time Factors | 3 | 2018 | 1681 | 0.070 |
Why?
|
Comorbidity | 3 | 2017 | 606 | 0.070 |
Why?
|
Lipodystrophy | 1 | 2005 | 7 | 0.070 |
Why?
|
Proteins | 1 | 2008 | 352 | 0.070 |
Why?
|
HIV Wasting Syndrome | 1 | 2005 | 7 | 0.070 |
Why?
|
Genotype | 2 | 2018 | 641 | 0.070 |
Why?
|
Glucose Intolerance | 1 | 2005 | 42 | 0.070 |
Why?
|
DNA | 3 | 2019 | 549 | 0.070 |
Why?
|
Carnitine | 1 | 2004 | 8 | 0.070 |
Why?
|
Child, Preschool | 2 | 2021 | 1318 | 0.060 |
Why?
|
Electron Transport Complex II | 2 | 2001 | 7 | 0.060 |
Why?
|
Electron Transport Complex I | 2 | 2016 | 20 | 0.060 |
Why?
|
Multienzyme Complexes | 2 | 2001 | 63 | 0.060 |
Why?
|
Apoptosis | 1 | 2011 | 1317 | 0.060 |
Why?
|
Phenotype | 2 | 2022 | 650 | 0.060 |
Why?
|
Thailand | 2 | 2015 | 48 | 0.060 |
Why?
|
Fatty Acids | 1 | 2004 | 118 | 0.060 |
Why?
|
Organ Specificity | 1 | 2004 | 123 | 0.060 |
Why?
|
Oxidation-Reduction | 2 | 2016 | 407 | 0.060 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2005 | 214 | 0.060 |
Why?
|
Risk Assessment | 1 | 2006 | 727 | 0.060 |
Why?
|
Heart Rate | 2 | 2017 | 248 | 0.060 |
Why?
|
Endonucleases | 2 | 1994 | 18 | 0.060 |
Why?
|
Fetal Blood | 1 | 2003 | 47 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 608 | 0.050 |
Why?
|
Mice | 3 | 2022 | 5668 | 0.050 |
Why?
|
Phosphorylation | 2 | 2016 | 878 | 0.050 |
Why?
|
Interleukin-17 | 1 | 2022 | 54 | 0.050 |
Why?
|
Blood Glucose | 2 | 2014 | 333 | 0.050 |
Why?
|
Chromatography, Ion Exchange | 1 | 2002 | 25 | 0.050 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2002 | 27 | 0.050 |
Why?
|
Cell Fractionation | 1 | 2002 | 28 | 0.050 |
Why?
|
Models, Biological | 1 | 2005 | 642 | 0.050 |
Why?
|
Aging | 2 | 2017 | 639 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 74 | 0.050 |
Why?
|
Indicators and Reagents | 1 | 2002 | 57 | 0.050 |
Why?
|
Blood Chemical Analysis | 1 | 2001 | 19 | 0.050 |
Why?
|
Microglia | 1 | 2023 | 152 | 0.050 |
Why?
|
Rats | 3 | 2001 | 3261 | 0.050 |
Why?
|
Injections, Intraperitoneal | 1 | 2001 | 58 | 0.050 |
Why?
|
Iron | 1 | 2023 | 204 | 0.050 |
Why?
|
Myocardium | 1 | 2004 | 224 | 0.050 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2021 | 5 | 0.050 |
Why?
|
Oxazines | 1 | 2021 | 23 | 0.050 |
Why?
|
Logistic Models | 2 | 2016 | 894 | 0.050 |
Why?
|
Magnesium | 1 | 2002 | 95 | 0.050 |
Why?
|
Ethanolamines | 1 | 2021 | 12 | 0.050 |
Why?
|
Risk | 1 | 2021 | 256 | 0.050 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 47 | 0.050 |
Why?
|
Phosphatidylethanolamines | 1 | 2021 | 22 | 0.050 |
Why?
|
Glycosylphosphatidylinositols | 1 | 2021 | 19 | 0.050 |
Why?
|
Lipogenesis | 1 | 2021 | 18 | 0.050 |
Why?
|
Rats, Inbred F344 | 1 | 2001 | 228 | 0.050 |
Why?
|
Pyridones | 1 | 2021 | 40 | 0.050 |
Why?
|
Kidney | 2 | 2001 | 322 | 0.050 |
Why?
|
Glycolysis | 1 | 2021 | 66 | 0.050 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 65 | 0.050 |
Why?
|
Regression Analysis | 1 | 2021 | 429 | 0.050 |
Why?
|
Sarcomeres | 1 | 2000 | 8 | 0.050 |
Why?
|
Liver | 2 | 2001 | 447 | 0.050 |
Why?
|
Piperazines | 1 | 2021 | 109 | 0.050 |
Why?
|
Metabolomics | 1 | 2021 | 76 | 0.050 |
Why?
|
Incidence | 2 | 2018 | 882 | 0.050 |
Why?
|
CD4-CD8 Ratio | 1 | 2020 | 28 | 0.050 |
Why?
|
Saccharomyces cerevisiae | 1 | 2002 | 193 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 445 | 0.050 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2019 | 18 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 150 | 0.050 |
Why?
|
Receptors, Immunologic | 1 | 2020 | 59 | 0.040 |
Why?
|
Mutagens | 1 | 2000 | 66 | 0.040 |
Why?
|
Organ Size | 1 | 2019 | 148 | 0.040 |
Why?
|
Brachial Artery | 2 | 2010 | 31 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2022 | 562 | 0.040 |
Why?
|
Statistics as Topic | 2 | 2009 | 111 | 0.040 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2000 | 155 | 0.040 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 179 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2005 | 592 | 0.040 |
Why?
|
Cytokines | 1 | 2021 | 569 | 0.040 |
Why?
|
Base Sequence | 2 | 2003 | 932 | 0.040 |
Why?
|
Glucose Tolerance Test | 1 | 2018 | 66 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2019 | 1961 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2022 | 1530 | 0.040 |
Why?
|
Homeostasis | 1 | 2019 | 172 | 0.040 |
Why?
|
Animals, Newborn | 2 | 2000 | 323 | 0.040 |
Why?
|
Pain Measurement | 2 | 2009 | 161 | 0.040 |
Why?
|
Feces | 1 | 2017 | 110 | 0.040 |
Why?
|
DNA Polymerase III | 2 | 1994 | 11 | 0.040 |
Why?
|
Education, Medical | 1 | 2018 | 97 | 0.040 |
Why?
|
Japan | 1 | 2017 | 296 | 0.040 |
Why?
|
Chromatography, Thin Layer | 1 | 2016 | 37 | 0.040 |
Why?
|
Heterozygote | 1 | 2016 | 91 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2016 | 41 | 0.030 |
Why?
|
Patient Compliance | 1 | 2017 | 202 | 0.030 |
Why?
|
Leg | 1 | 2015 | 20 | 0.030 |
Why?
|
Longevity | 1 | 2017 | 143 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2021 | 1149 | 0.030 |
Why?
|
Centrifugation, Density Gradient | 1 | 1995 | 22 | 0.030 |
Why?
|
DNA, Single-Stranded | 1 | 1995 | 36 | 0.030 |
Why?
|
Survivors | 1 | 2016 | 126 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2016 | 528 | 0.030 |
Why?
|
Lipoproteins | 1 | 2014 | 61 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1995 | 249 | 0.030 |
Why?
|
Thymus Gland | 1 | 1995 | 77 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2016 | 570 | 0.030 |
Why?
|
Particle Size | 1 | 2014 | 200 | 0.030 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 1994 | 12 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 325 | 0.030 |
Why?
|
Haplotypes | 1 | 2014 | 152 | 0.030 |
Why?
|
Oxygen | 1 | 2014 | 193 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2014 | 281 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2014 | 131 | 0.030 |
Why?
|
Puerto Rico | 1 | 2018 | 1352 | 0.030 |
Why?
|
Age Factors | 1 | 2016 | 1007 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 468 | 0.030 |
Why?
|
Stem Cells | 1 | 1994 | 132 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 145 | 0.030 |
Why?
|
Sex Factors | 1 | 2016 | 859 | 0.030 |
Why?
|
Hemoglobins | 1 | 2012 | 101 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2012 | 137 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 1995 | 1124 | 0.030 |
Why?
|
Age Distribution | 1 | 2012 | 223 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 1995 | 1490 | 0.030 |
Why?
|
Arteries | 1 | 2011 | 67 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2017 | 2333 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 424 | 0.020 |
Why?
|
Specimen Handling | 1 | 2011 | 49 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2010 | 57 | 0.020 |
Why?
|
Cells, Cultured | 1 | 1994 | 1442 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 1994 | 1534 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2009 | 151 | 0.020 |
Why?
|
HIV Protease Inhibitors | 1 | 2008 | 22 | 0.020 |
Why?
|
Immunoassay | 1 | 2008 | 57 | 0.020 |
Why?
|
Body Mass Index | 1 | 2012 | 775 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2011 | 901 | 0.020 |
Why?
|
Sural Nerve | 1 | 2007 | 4 | 0.020 |
Why?
|
Neural Conduction | 1 | 2007 | 19 | 0.020 |
Why?
|
Neuralgia | 1 | 2007 | 13 | 0.020 |
Why?
|
Cell Line | 1 | 2011 | 1289 | 0.020 |
Why?
|
Diet | 1 | 2012 | 747 | 0.020 |
Why?
|
Action Potentials | 1 | 2007 | 219 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2005 | 148 | 0.010 |
Why?
|
DNA, Viral | 1 | 2005 | 295 | 0.010 |
Why?
|
Body Weight | 1 | 2005 | 404 | 0.010 |
Why?
|
DNA Primers | 1 | 2003 | 269 | 0.010 |
Why?
|
Haplorhini | 1 | 2000 | 21 | 0.010 |
Why?
|
Cerebellum | 1 | 2000 | 69 | 0.010 |
Why?
|
Spleen | 1 | 1991 | 192 | 0.010 |
Why?
|
Kinetics | 1 | 1991 | 650 | 0.010 |
Why?
|